At a glance
ClinicalIndex Comparison RecordN/ACompleted· 300 enrolled
Drug / intervention
Serologic testingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
In Brief
A clinical study evaluating Serologic testing for SARS-CoV 2 and COVID-19. Completed, enrolled 300 participants across 1 site.
Detailed Summary
The purpose of this study is to identify healthcare workers with SARS CoV 2 antibodies who have not been previously diagnosed and are presumed COVID-19 negative, then determine the level of immunity in this population which could inform further decisions about widespread antibody testing in a healthcare worker population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSARS-CoV 2, COVID-19
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMay 2020
First PostedMay 2020
Primary CompletionJul 2020
Study CompletionJul 2020
TodayJul 2026
First PostedMay 12, 2020
Enrollment StartMay 6, 2020
Primary CompletionJul 1, 2020
Study CompletionJul 31, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.1 years ago
Interventions
Serologic testingother
COVID19 IgG antibody testing to be performed